Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent
- Bioorg Med Chem Lett. 2012 Jan 15;22(2):1049-54. doi: 10.1016/j.bmcl.2011.11.119.
- 1. Molecular Innovative Therapeutics, Sanofi Pharmaceuticals, USA. [email protected]
A solid phase combinatorial library was designed based on X-ray structures and in-silico models to explore an inducible S4+ pocket, which is formed by a simple side-chain rotation of Tyr95. This inducible S4+ pocket is unique to β-tryptase and does not exist for Other trypsin-like serine proteases of interest. Therefore, inhibitors utilizing this pocket have inherent advantages for being selective against Other proteases in the same family. A member of this library was found to be a potent and selective β-tryptase inhibitor with a suitable pharmacokinetic profile for further clinical evaluation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Ser/Thr ProteaseResearch Areas: Inflammation/Immunology
-
target: Ser/Thr ProteaseResearch Areas: Inflammation/Immunology